# tables/lab-results/lbt09.qmd result_v1 stable

    Code
      print(data_snap[[i]])
    Output
                                                                             A: Drug X                        B: Placebo                      C: Combination         
      Liver Laboratory Test Criterion                                BASELINE      POST-BASELINE       BASELINE      POST-BASELINE       BASELINE      POST-BASELINE 
      ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total Bilirubin <= 2xULN                                                                                                                                       
        ALT >3 - <= 5xULN                                         23/134 (17.2%)   15/134 (11.2%)   25/134 (18.7%)   27/134 (20.1%)   27/132 (20.5%)   30/132 (22.7%)
        ALT >5 - <= 10xULN                                        28/134 (20.9%)   29/134 (21.6%)   29/134 (21.6%)   19/134 (14.2%)   36/132 (27.3%)   29/132 (22.0%)
        ALT >10 - <= 20xULN                                       24/134 (17.9%)   30/134 (22.4%)   32/134 (23.9%)   33/134 (24.6%)   28/132 (21.2%)   24/132 (18.2%)
        ALT > 20xULN                                              32/134 (23.9%)   35/134 (26.1%)   24/134 (17.9%)   23/134 (17.2%)   20/132 (15.2%)   26/132 (19.7%)
        AST >3 - <= 5xULN                                         31/134 (23.1%)   34/134 (25.4%)   30/134 (22.4%)   26/134 (19.4%)   34/132 (25.8%)   24/132 (18.2%)
        AST >5 - <= 10xULN                                        25/134 (18.7%)   25/134 (18.7%)   26/134 (19.4%)   26/134 (19.4%)   22/132 (16.7%)   27/132 (20.5%)
        AST >10 - <= 20xULN                                       22/134 (16.4%)   29/134 (21.6%)   16/134 (11.9%)   22/134 (16.4%)   34/132 (25.8%)   19/132 (14.4%)
        AST > 20xULN                                              20/134 (14.9%)   16/134 (11.9%)   28/134 (20.9%)   31/134 (23.1%)   21/132 (15.9%)   39/132 (29.5%)
      Total Bilirubin > 2xULN                                                                                                                                        
        ALT >3 - <= 5xULN                                         40/134 (29.9%)   28/134 (20.9%)   31/134 (23.1%)   28/134 (20.9%)   18/132 (13.6%)   32/132 (24.2%)
        ALT >5 - <= 10xULN                                        24/134 (17.9%)   29/134 (21.6%)   30/134 (22.4%)   37/134 (27.6%)   33/132 (25.0%)   24/132 (18.2%)
        ALT >10 - <= 20xULN                                       24/134 (17.9%)   22/134 (16.4%)   26/134 (19.4%)   18/134 (13.4%)   21/132 (15.9%)   30/132 (22.7%)
        ALT > 20xULN                                              19/134 (14.2%)   33/134 (24.6%)   23/134 (17.2%)   19/134 (14.2%)   30/132 (22.7%)   22/132 (16.7%)
        AST >3 - <= 5xULN                                         17/134 (12.7%)   27/134 (20.1%)   36/134 (26.9%)   25/134 (18.7%)   26/132 (19.7%)   34/132 (25.8%)
        AST >5 - <= 10xULN                                        25/134 (18.7%)   28/134 (20.9%)   24/134 (17.9%)   28/134 (20.9%)   20/132 (15.2%)   23/132 (17.4%)
        AST >10 - <= 20xULN                                       36/134 (26.9%)   28/134 (20.9%)   16/134 (11.9%)   26/134 (19.4%)   33/132 (25.0%)   26/132 (19.7%)
        AST > 20xULN                                              30/134 (22.4%)   21/134 (15.7%)   30/134 (22.4%)   24/134 (17.9%)   24/132 (18.2%)   25/132 (18.9%)
      Total Bilirubin > 2xULN and Alkaline Phosphatase <= 2xULN                                                                                                      
        ALT >3 - <= 5xULN                                         24/134 (17.9%)   22/134 (16.4%)   28/134 (20.9%)   23/134 (17.2%)   38/132 (28.8%)   23/132 (17.4%)
        ALT >5 - <= 10xULN                                        26/134 (19.4%)   25/134 (18.7%)   19/134 (14.2%)   22/134 (16.4%)   32/132 (24.2%)   32/132 (24.2%)
        ALT >10 - <= 20xULN                                       26/134 (19.4%)   30/134 (22.4%)   31/134 (23.1%)   30/134 (22.4%)   21/132 (15.9%)   27/132 (20.5%)
        ALT > 20xULN                                              30/134 (22.4%)   28/134 (20.9%)   24/134 (17.9%)   36/134 (26.9%)   20/132 (15.2%)   23/132 (17.4%)
        AST >3 - <= 5xULN                                         37/134 (27.6%)   25/134 (18.7%)   31/134 (23.1%)   26/134 (19.4%)   24/132 (18.2%)   36/132 (27.3%)
        AST >5 - <= 10xULN                                        25/134 (18.7%)   32/134 (23.9%)   29/134 (21.6%)   30/134 (22.4%)   26/132 (19.7%)   24/132 (18.2%)
        AST >10 - <= 20xULN                                       25/134 (18.7%)   31/134 (23.1%)   28/134 (20.9%)   22/134 (16.4%)   29/132 (22.0%)   23/132 (17.4%)
        AST > 20xULN                                              26/134 (19.4%)   25/134 (18.7%)   23/134 (17.2%)   30/134 (22.4%)   23/132 (17.4%)   24/132 (18.2%)
      Total Bilirubin > 2xULN and Alkaline Phosphatase <= 5xULN                                                                                                      
        ALT >3 - <= 5xULN                                         24/134 (17.9%)   21/134 (15.7%)   30/134 (22.4%)   17/134 (12.7%)   28/132 (21.2%)   31/132 (23.5%)
        ALT >5 - <= 10xULN                                        36/134 (26.9%)   28/134 (20.9%)   25/134 (18.7%)   27/134 (20.1%)   26/132 (19.7%)   29/132 (22.0%)
        ALT >10 - <= 20xULN                                       30/134 (22.4%)   21/134 (15.7%)   28/134 (20.9%)   36/134 (26.9%)   25/132 (18.9%)   24/132 (18.2%)
        ALT > 20xULN                                              14/134 (10.4%)   28/134 (20.9%)   25/134 (18.7%)   27/134 (20.1%)   31/132 (23.5%)   23/132 (17.4%)
        AST >3 - <= 5xULN                                         21/134 (15.7%)   26/134 (19.4%)   29/134 (21.6%)   31/134 (23.1%)   33/132 (25.0%)   19/132 (14.4%)
        AST >5 - <= 10xULN                                        29/134 (21.6%)   26/134 (19.4%)   24/134 (17.9%)   26/134 (19.4%)   23/132 (17.4%)   32/132 (24.2%)
        AST >10 - <= 20xULN                                       29/134 (21.6%)   31/134 (23.1%)   28/134 (20.9%)   22/134 (16.4%)   22/132 (16.7%)   21/132 (15.9%)
        AST > 20xULN                                              34/134 (25.4%)   21/134 (15.7%)   19/134 (14.2%)   28/134 (20.9%)   21/132 (15.9%)   33/132 (25.0%)

# tables/lab-results/lbt09.qmd result_v2 stable

    Code
      print(data_snap[[i]])
    Output
                                                                             A: Drug X                        B: Placebo                      C: Combination         
      Liver Laboratory Test Criterion                                BASELINE      POST-BASELINE       BASELINE      POST-BASELINE       BASELINE      POST-BASELINE 
      ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total Bilirubin <= 2xULN                                                                                                                                       
        ALT >3 - <= 5xULN                                         23/134 (17.2%)   15/134 (11.2%)   25/134 (18.7%)   27/134 (20.1%)   27/132 (20.5%)   30/132 (22.7%)
        ALT >5 - <= 10xULN                                        28/134 (20.9%)   29/134 (21.6%)   29/134 (21.6%)   19/134 (14.2%)   36/132 (27.3%)   29/132 (22.0%)
        ALT >10 - <= 20xULN                                       24/134 (17.9%)   30/134 (22.4%)   32/134 (23.9%)   33/134 (24.6%)   28/132 (21.2%)   24/132 (18.2%)
        ALT > 20xULN                                              32/134 (23.9%)   35/134 (26.1%)   24/134 (17.9%)   23/134 (17.2%)   20/132 (15.2%)   26/132 (19.7%)
        AST >3 - <= 5xULN                                         31/134 (23.1%)   34/134 (25.4%)   30/134 (22.4%)   26/134 (19.4%)   34/132 (25.8%)   24/132 (18.2%)
        AST >5 - <= 10xULN                                        25/134 (18.7%)   25/134 (18.7%)   26/134 (19.4%)   26/134 (19.4%)   22/132 (16.7%)   27/132 (20.5%)
        AST >10 - <= 20xULN                                       22/134 (16.4%)   29/134 (21.6%)   16/134 (11.9%)   22/134 (16.4%)   34/132 (25.8%)   19/132 (14.4%)
        AST > 20xULN                                              20/134 (14.9%)   16/134 (11.9%)   28/134 (20.9%)   31/134 (23.1%)   21/132 (15.9%)   39/132 (29.5%)
      Total Bilirubin > 2xULN                                                                                                                                        
        ALT >3 - <= 5xULN                                         40/134 (29.9%)   28/134 (20.9%)   31/134 (23.1%)   28/134 (20.9%)   18/132 (13.6%)   32/132 (24.2%)
        ALT >5 - <= 10xULN                                        24/134 (17.9%)   29/134 (21.6%)   30/134 (22.4%)   37/134 (27.6%)   33/132 (25.0%)   24/132 (18.2%)
        ALT >10 - <= 20xULN                                       24/134 (17.9%)   22/134 (16.4%)   26/134 (19.4%)   18/134 (13.4%)   21/132 (15.9%)   30/132 (22.7%)
        ALT > 20xULN                                              19/134 (14.2%)   33/134 (24.6%)   23/134 (17.2%)   19/134 (14.2%)   30/132 (22.7%)   22/132 (16.7%)
        AST >3 - <= 5xULN                                         17/134 (12.7%)   27/134 (20.1%)   36/134 (26.9%)   25/134 (18.7%)   26/132 (19.7%)   34/132 (25.8%)
        AST >5 - <= 10xULN                                        25/134 (18.7%)   28/134 (20.9%)   24/134 (17.9%)   28/134 (20.9%)   20/132 (15.2%)   23/132 (17.4%)
        AST >10 - <= 20xULN                                       36/134 (26.9%)   28/134 (20.9%)   16/134 (11.9%)   26/134 (19.4%)   33/132 (25.0%)   26/132 (19.7%)
        AST > 20xULN                                              30/134 (22.4%)   21/134 (15.7%)   30/134 (22.4%)   24/134 (17.9%)   24/132 (18.2%)   25/132 (18.9%)
      Total Bilirubin > 2xULN and Alkaline Phosphatase <= 5xULN                                                                                                      
        ALT >3 - <= 5xULN                                         24/134 (17.9%)   21/134 (15.7%)   30/134 (22.4%)   17/134 (12.7%)   28/132 (21.2%)   31/132 (23.5%)
        ALT >5 - <= 10xULN                                        36/134 (26.9%)   28/134 (20.9%)   25/134 (18.7%)   27/134 (20.1%)   26/132 (19.7%)   29/132 (22.0%)
        ALT >10 - <= 20xULN                                       30/134 (22.4%)   21/134 (15.7%)   28/134 (20.9%)   36/134 (26.9%)   25/132 (18.9%)   24/132 (18.2%)
        ALT > 20xULN                                              14/134 (10.4%)   28/134 (20.9%)   25/134 (18.7%)   27/134 (20.1%)   31/132 (23.5%)   23/132 (17.4%)
        AST >3 - <= 5xULN                                         21/134 (15.7%)   26/134 (19.4%)   29/134 (21.6%)   31/134 (23.1%)   33/132 (25.0%)   19/132 (14.4%)
        AST >5 - <= 10xULN                                        29/134 (21.6%)   26/134 (19.4%)   24/134 (17.9%)   26/134 (19.4%)   23/132 (17.4%)   32/132 (24.2%)
        AST >10 - <= 20xULN                                       29/134 (21.6%)   31/134 (23.1%)   28/134 (20.9%)   22/134 (16.4%)   22/132 (16.7%)   21/132 (15.9%)
        AST > 20xULN                                              34/134 (25.4%)   21/134 (15.7%)   19/134 (14.2%)   28/134 (20.9%)   21/132 (15.9%)   33/132 (25.0%)

